Commodore Capital’s BELLUS Health Inc. BLU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-6,579,359
Closed -$47.4M 33
2023
Q1
$47.4M Buy
6,579,359
+1,275,802
+24% +$9.9M 7.21% 5
2022
Q4
$43.6M Buy
5,303,557
+175,000
+3% +$1.63M 6.57% 4
2022
Q3
$54.2M Buy
5,128,557
+648,773
+14% +$6.89M 8.71% 4
2022
Q2
$41.4M Sell
4,479,784
-1,157,846
-21% -$9.47M 8.75% 4
2022
Q1
$38.8M Buy
5,637,630
+2,513,017
+80% +$16.2M 8.66% 3
2021
Q4
$25.2M Buy
+3,124,613
New +$20.7M 5.83% 7

Other funds holding BLU

Commodore Capital's BLU Position: Q2 2023 in Review

Commodore Capital sold out of BELLUS Health Inc. (BLU) in Q2 2023, closing a stake of 6,579,359 shares — an estimated $47.4M sold.

Commodore Capital first reported a position in BLU in Q4 2021 and held it in 6 quarters. The position peaked at $54.2M in Q3 2022. 11 funds tracked by Wall St. Rank hold BLU as of Q2 2023.

  • Commodore Capital reported no remaining BELLUS Health Inc. position as of Q2 2023 after selling out during the quarter.
  • Commodore Capital sold 6,579,359 BELLUS Health Inc. shares in Q2 2023, an estimated $47.4M.
  • Commodore Capital first reported a position in BELLUS Health Inc. in Q4 2021 and held it in 6 quarters.
  • Commodore Capital's BELLUS Health Inc. position peaked at $54.2M in Q3 2022.
  • 11 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q2 2023.

Based on Commodore Capital's 13F filing for Q2 2023, filed 14 Aug 2023.